IL2 and glioblastoma: To determine whether primary NK cells, cultured in NK MACS® medium supplemented with human AB serum and IL-2, have the cytotoxic capacity to effectively lyse primary cancer stem cells, killing assays were conducted using different glioblastoma cancer stem cells as target cells.